| CTRI Number |
CTRI/2024/04/066053 [Registered on: 22/04/2024] Trial Registered Prospectively |
| Last Modified On: |
22/04/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug |
| Study Design |
Other |
|
Public Title of Study
|
IMPACT OF INTERVENTION WITH FRUSEMIDE(LASIX)/DIALYSIS COMPARED WITH STANDARD INTERVENTION IN CRITICALLY ILL/ICU PATIENTS ON DEATH IN A TERTIARY CARE HOSPITAL |
|
Scientific Title of Study
|
IMPACT OF PROTOCOLIZED DE-RESUSCITATION WITH FRUSEMIDE/RENAL REPLACEMENT THERAPY COMPARED WITH STANDARD INTERVENTION IN CRITICALLY ILL PATIENTS ON MORTALITY IN A TERTIARY CARE HOSPITAL |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
AMRITA SHAH |
| Designation |
DrNB Trainee |
| Affiliation |
Manipal hospitals yeshwanthpur |
| Address |
CRITICAL CARE MEDICINE
ICU 1 ST FLOOR
Manipal Hospitals Yeshwanthpur,
Brigade Gateway 26, 4, 1st Main Rd, beside Metro, Malleshwaram, Bengaluru,
Bangalore KARNATAKA 560055 India |
| Phone |
9864872622 |
| Fax |
|
| Email |
shahamrita8@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DR PRADEEP RANGAPPA |
| Designation |
CONSULTANT/GUIDE |
| Affiliation |
Manipal hospitals yeshwanthpur |
| Address |
Manipal Hospitals Yeshwanthpur,
Brigade Gateway 26, 4, 1st Main Rd, beside Metro, Malleshwaram, Bengaluru,
Bangalore KARNATAKA 560055 India |
| Phone |
9864872622 |
| Fax |
|
| Email |
prangap939@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
AMRITA SHAH |
| Designation |
DrNB Trainee |
| Affiliation |
Manipal hospitals yeshwanthpur |
| Address |
CRITICAL CARE MEDICINE
ICU 1 ST FLOOR
Manipal Hospitals Yeshwanthpur,
Brigade Gateway 26, 4, 1st Main Rd, beside Metro, Malleshwaram, Bengaluru,
Bangalore KARNATAKA 560055 India |
| Phone |
9864872622 |
| Fax |
|
| Email |
shahamrita8@gmail.com |
|
|
Source of Monetary or Material Support
|
| CRITICAL CARE MEDICINE
ICU 1ST FLOOR
MANIPAL HOSPITAL YESHWANTHPUR, Inside Brigade gateway, Malleshwaram, 560066 |
|
|
Primary Sponsor
|
| Name |
AMRITA SHAH |
| Address |
MANIPAL HOSPITALS YESHWANTHPUR,
|
| Type of Sponsor |
Private hospital/clinic |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| AMRITA SHAH |
MANIPAL HOSPITALS YESHWANTHPUR |
Brigade Gateway 26, 4, 1st Main Rd, beside Metro, Malleshwaram, Bengaluru, Karnataka 560055 Bangalore KARNATAKA |
9864872622
shahamrita8@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee Columbia Asia Hospitals |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: R098||Other specified symptoms and signsinvolving the circulatory and respiratory systems, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
FRUSEMIDE/RENAL REPLACEMENT THERAPY
STANDARD THERAPY |
Frusemide (Injection Lasix 20 mg) 0.5 mg/kg bolus f/b infusion 2.5 mg/hour ïƒ titrated to achieve negative balance 1L /day after D3 for 2 days. If target not achieved, can be increased upto 20 mg/hour (RADAR-2 trial).
Diuretics not considered if patient on Renal replacement therapy.
If no evidence of fluid overload/negative balance achieved after day 3-day 5 ïƒ target neutral balance
If presence of fluid overload between day 3/day of stabilization-day 5/48 hours post stabilization, then active de-resuscitation followed.
Intervention: Aimed at targeting negative or neutral balance depending on net balance after D3/day of stabilization -D5/48 hours after stabilization in the 1st week.
|
| Comparator Agent |
STANDARD THERAPY |
TARGETING A NEGATIVE BALANCE FROM D3/DAY OF STABILIZATION |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
99.00 Year(s) |
| Gender |
Both |
| Details |
At least 2 days of ICU admission
Older than 18 years
|
|
| ExclusionCriteria |
| Details |
1. Patient’s refusal.
2. Patient younger than 18 years.
3. Length of ICU stay < 2 days
4. Lactates>4
5. Norepinephrine/epinephrine> 0.2 mcg/kg/min/>1 vasopressor in use
6. Patients with subarachnoid haemorrhage
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Mortality at 28 days |
28 DAYS |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Hospital and ICU mortality
Mechanical ventilator free days
ICU length of stay (ICU-LOS)
New adverse effects – hypernatremia, metabolic alkalosis, new AKI
Change in SOFA Score
|
28 DAY |
|
|
Target Sample Size
|
Total Sample Size="198" Sample Size from India="198"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
05/05/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
not applicable yet |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identification.
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form Response - Clinical Study Report
- Who will be able to view these files?
Response - Anyone
- For what types of analyses will this data be available?
Response - Any purpose.
- By what mechanism will data be made available?
Response (Others) -
- For how long will this data be available start date provided 05-05-2024 and end date provided 11-05-2025?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
Fluid administration in ICU has been divided 4 phases: Resuscitation, Optimisation, Stabilisation, and Evacuation (ROSE), followed by risk of Hypoperfusion. Intravenous fluid is administered during initial phase of resuscitation to counter dehydration, as diluents to give medications and in cases of shock.1 In certain cases, this can result in a positive fluid balance. During stabilization phase, we target for late Conservative Fluid Management (LCFM) and during evacuation phase goal directed fluid removal is advocated. Malbrain et al (2014) defined late Conservative Fluid Management (LCFM) as two consecutive days of negative fluid balance within the first week of ICU stay. Late Goal Directed Fluid Removal (LGFR) – defined as more aggressive and active fluid removal by means of diuretics and renal replacement therapy with net ultrafiltration.1 A positive cumulative fluid balance in critically ill patients have been associated with poor clinical outcomes including poly-compartment syndrome, increased mortality and intra-abdominal hypertension.1 In septic patients, a positive fluid balance was found to be a strongest predictors of death.2 The fluid overload state can result in affecting the cardiovascular system (causing myocardial oedema, conduction disturbance, impaired contractility, diastolic dysfunction, myocardial depression, pericardial effusion), central nervous system(cerebral oedema, impaired cognition, delirium , increased intracranial pressure, cerebral perfusion pressure and intra-ocular pressure), respiratory system( causing pulmonary oedema, pleural effusion, altered pulmonary and chest wall elastance, impaired gas exchange and increased work of breathing), gastrointestinal system(impaired synthetic function, cholestasis, Impaired cytochrome P 450 activity, hepatic compartment syndrome), renal system(renal interstitial oedema, increased renal blood flow, increased renal vascular resistance ,salt retention , water retention and renal compartment syndrome), gastro-intestinal system(ascites formation, gut oedema ,malabsorption ,ileus , increased Abdominal perfusion pressure, increased Bowel contractility , increased IAP and APP and abdominal compartment syndrome).1 A positive fluid balance is independently associated with impaired organ function and an increased risk of death.2,3 Following hemodynamic stabilization, it is important to understand whether liberal or conservative fluid management and strategic removal of excess fluid impacts ICU outcomes. The reason we have taken up this study is -even though most studies have mentioned a positive fluid balance is harmful after optimal stabilization1,2,3, studies on how much, methods of removal and to what extent the removal of excess fluids can help in such outcomes are varied and with variable results. We have designed a protocol for the same to assess its impact on clinical outcomes.
- Malbrain, Manu & Marik, Paul & Witters, Ine & Cordemans, Colin & Kirkpatrick, Andrew & Roberts, Derek & Regenmortel, Niels. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: A systematic review with suggestions for clinical practice. Anaesthesiology intensive therapy.Nov 2014;46(5):361-80
- Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D; Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006 Feb;34(2):344-53.
- Murphy CV, Schramm GE, Doherty JA et al.: The importance of fluid management in acute lung injury secondary to septic shock. Chest 2009; 136: 102�’109.
|